Advantages of EVOH Resin in Embolic Medical Consumables

In modern medicine, vascular embolization technology has become an essential treatment method for various diseases, including tumor embolization therapy, aneurysm repair, hemorrhage control, and arteriovenous malformation treatment.

In the research and application of embolic materials, EVOH (ethylene-Vinyl Alcohol Copolymer) resin is gradually becoming one of the preferred choices for high-end medical embolization materials due to its outstanding properties.

Vascular Embolization and Requirements for Embolic Materials

Vascular embolization is a minimally invasive interventional therapy in which embolic materials are delivered to the lesion site through a catheter to block blood supply to the diseased vessel, achieving therapeutic effects. Common embolic materials include metal microcoils, gelatin sponge particles, polyvinyl alcohol (PVA) particles, and liquid embolic agents such as NBCA.

When selecting embolic materials, several key factors must be considered:

(1)Controllability: The embolic material should have good fluidity and plasticity to ensure precise delivery to the target vessel.

(2)Biocompatibility: It must avoid causing inflammatory or allergic reactions.

(3)Barrier Performance: It should effectively block blood flow and maintain long-term embolization.

(4)Visibility: It must have good visibility under imaging guidance for precise operation.

(5)Degradability (in specific applications): In some cases, the embolic material needs to be degradable to allow vascular recanalization.

With the advancement of medical technology, the requirements for embolic materials are becoming increasingly stringent. The emergence of EVOH polymer provides a superior material choice for vascular embolization.

Advantages of Evoh Resin in Embolic Materials

(1) Excellent Barrier Performance for Effective Embolization

EVOH plastic has extremely low gas and liquid permeability, effectively blocking blood flow and ensuring prolonged embolization effects. Compared to traditional PVA particles or NBCA (cyanoacrylate) glue, EVOH-based liquid embolic agents demonstrate superior long-term vessel occlusion, reducing the likelihood of embolization failure.

(2) High X-ray Visibility for Precision Operation

EVOH material itself is a highly transparent material but can be compounded with high-density metal particles such as yttrium (Y), tantalum (Ta), or barium (Ba) to achieve excellent radiopacity under X-ray or DSA (digital subtraction angiography) imaging. This property enables doctors to precisely control the delivery of embolic materials, improving procedural safety and success rates.

(3) Adjustable Rheological Properties for Customization

EVOH granules can be combined with solvents such as DMSO (N-methylpyrrolidone) to form embolic liquids with different viscosities. After solvent evaporation, EVOH rapidly solidifies to form a stable embolic layer. This adjustable rheological property makes it suitable for embolization of blood vessels of various sizes and shapes, achieving more precise therapeutic outcomes.

(4)Superior Biocompatibility to Reduce Complications

Unlike traditional NBCA, which solidifies instantly and may cause acute inflammation, EVOH  barrier material forms a gel-like structure within the blood vessel, minimizing inflammatory reactions and reducing post-procedural complications. Additionally, EVOH is non-cytotoxic and does not cause significant allergic or rejection responses.

(5)Multi-Layer Structure for Enhanced Functionality

EVOH resin can be co-extruded with high-performance polymers such as polyamide (PA), polyethylene (PE), and polypropylene (PP) to form multi-layer structures, improving mechanical strength, durability, and biostability. For example, in applications such as composite microspheres and embolic gel materials, EVOH serves as a core barrier layer to optimize material performance.

Cutting-Edge Applications of EVOH in Vascular Embolization

(1)Onyx™ EVOH Embolic Agent (Medtronic): Used for treating arteriovenous malformations (AVMs) and hemorrhagic lesions, offering excellent embolization effects and visibility.

(2)PHIL EVOH Liquid Embolic Agent (MicroVention): An optimized EVOH formulation with better viscosity control in DMSO solutions, suitable for a broader range of vascular malformation treatments.

(3)EVOH Composite Microspheres: Used in interventional vascular therapy, EVOH-coated microspheres enable precise vascular occlusion and reduce the risk of recanalization after embolization.

EVOH resin, with its superior barrier properties, excellent biocompatibility, adjustable rheological characteristics, and outstanding X-ray visibility, has demonstrated immense potential in embolic material applications. As demand for high-end medical devices grows, the market prospects for EVOH in the medical consumables sector will continue to expand.

As a professional EVOH resin manufacturer, we are committed to providing high-performance, high-safety EVOH solutions to the global medical industry, contributing to the advancement of minimally invasive interventional therapies.